DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Sonesson C, Johansson PA, Johnsson E. et al.
Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta‑analysis.
Cardiovasc Diabetol 2016;
15: 37
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.